IQV006 VT Infographicof patients participate in clinical research 48% of trial sites miss enrollment...

CONTACT USwww.IQVIA.com/virtualtrials © 2018 IQVIA. All rights reserved. IN.0018-1-06.2018

IQVIA™ VIRTUAL TRIALSAccelerate your timelines withpatient-centered drug development

THE CHALLENGES

THE SITUATION

49% of participants drop out before study completion

<5%of patients participate in clinical research

48%of trial sites miss enrollment targets

50miaverage distance patient lives from nearest site

THE SOLUTION

THE DIFFERENCE

IQVIA Virtual Trials

See how IQVIA Virtual Trials can help you advance clinical development.

Delivered direct-to-patients at home, IQVIA Virtual Trials can expand your reach and provide access to diverse populations and difficult-to-recruit candidates, solving the toughest clinical study challenges.

• At-home delivery increases participation• Direct-to-patient approach accelerates recruitment • Personalized interaction maximizes retention• Virtual study team facilitates patient journey

• Secure SaaS platform IQVIA™ Study Hub captures and integrates study activity• Mobile, connected devices enhance data gathering• Centralized collection reduces variability• Near real-time access enhances safety signal detection

• Streamlined engagement, enrollment, trial management • Fewer physical site visit costs• Centrally managed workflows, monitoring and communications improve efficiency

Speed to market

Hard-to-recruit sub-populations

Rapid recruitment

Participantdiversity

Patientretention

Costefficiencies

IMPROVE DATA QUALITY REDUCE COSTSPEED TIME TO MARKET

Poised to transform clinical research, IQVIA Virtual Trials are scalable and flexible, and can be executed asfull virtual or hybrid studies—large or small, local or global.

Virtual principal investigators and local healthcare networks

Globalsolution

End-to-end virtual delivery platform

Therapeutic and regulatory specialists